(Q45366611)

13 December 2017

title

Pharmacological response of human cardiomyocytes derived from virus-free induced pluripotent stem cells (English)

1 reference

Human Induced Pluripotent Stem Cells

13 December 2017

0 references

1 reference

1 reference

Ashish Mehta

1

1 reference

13 December 2017

Ying Ying Chung

2

1 reference

13 December 2017

Alvin Ng

3

1 reference

13 December 2017

Fahamy Iskandar

4

1 reference

13 December 2017

Shirhan Atan

5

1 reference

13 December 2017

Heming Wei

6

1 reference

13 December 2017

Greg Dusting

7

1 reference

13 December 2017

William Sun

8

1 reference

13 December 2017

Philip Wong

9

1 reference

13 December 2017

Winston Shim

10

1 reference

13 December 2017

publication date

12 May 2011

1 reference

13 December 2017

published in

Cardiovascular Research

1 reference

13 December 2017

volume

91

1 reference

13 December 2017

issue

4

1 reference

13 December 2017

page(s)

577-586

1 reference

describes a project that uses

13 December 2017

0 references

0 references

0 references

0 references

0 references

Embryonic stem cell lines derived from human blastocysts

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVR132

Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVR132

Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVR132

Dissecting hematopoietic differentiation using the embryonic stem cell differentiation model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVR132

Monoisoamyl dimercaptosuccinic acid abrogates arsenic-induced developmental toxicity in human embryonic stem cell-derived embryoid bodies: comparison with in vivo studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVR132

Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVR132

G-CSF for stem cell therapy in acute myocardial infarction: friend or foe?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVR132

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVR132

Induced pluripotent stem cell lines derived from human somatic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVR132

Patient-specific induced pluripotent stem-cell models for long-QT syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVR132

Cardiomyocyte differentiation of human induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVR132

Human induced pluripotent stem cells free of vector and transgene sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVR132

Generation of germline-competent induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVR132

Human iPS cell-based therapy: considerations before clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVR132

Generation of transgene-free induced pluripotent mouse stem cells by the piggyBac transposon

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVR132

A nonviral minicircle vector for deriving human iPS cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVR132

Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVR132

Assessment of drug induced developmental toxicity using human embryonic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVR132

Intrinsic properties and external factors determine the differentiation bias of human embryonic stem cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVR132

Enhanced cardiomyogenesis of human embryonic stem cells by a small molecular inhibitor of p38 MAPK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVR132

Fate mapping of human embryonic stem cells by teratoma formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVR132

Local control of excitation-contraction coupling in human embryonic stem cell-derived cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVR132

Functional cardiomyocytes derived from human induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVR132

Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVR132

Marked differences in differentiation propensity among human embryonic stem cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVR132

Distinct cardiogenic preferences of two human embryonic stem cell (hESC) lines are imprinted in their proteomes in the pluripotent state

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVR132

Substantial variation in the cardiac differentiation of human embryonic stem cell lines derived and propagated under the same conditions--a comparison of multiple cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVR132

Oct-3/4 dose dependently regulates specification of embryonic stem cells toward a cardiac lineage and early heart development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVR132

Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVR132

Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVR132

Differentiation in vivo of cardiac committed human embryonic stem cells in postmyocardial infarcted rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVR132

Cardiomyocytes from human pluripotent stem cells in regenerative medicine and drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVR132

Can the pharmaceutical industry reduce attrition rates?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVR132

Drug-induced prolongation of the QT interval

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVR132

Mechanism of spontaneous excitability in human embryonic stem cell derived cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVR132

Early afterdepolarizations in cardiac myocytes: mechanism and rate dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVR132

Functional characterization of cardiomyocytes derived from murine induced pluripotent stem cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVR132

In vitro pharmacologic testing using human induced pluripotent stem cell-derived cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVR132

Modelling the long QT syndrome with induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVR132

Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVR132

Strategies and new developments in the generation of patient-specific pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVR132

The promise of human induced pluripotent stem cells for research and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVR132

Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVR132

21 January 2018

Identifiers

DOI

10.1093/CVR/CVR132

1 reference

13 December 2017

1 reference